Death of a president and his assassin--errors in their diagnosis and autopsies.

J Hist Neurosci

The Ohio State University, Institute for Collaborative Research and Public Humanities, Columbus, Ohio 43201-1654, USA.

Published: June 2006

On July 2, 1881, Charles Julius Guiteau shot President James Abram Garfield in the right flank. The President died because of infection produced by the unsterile fingers and probes repeatedly inserted into the wound. The major complaint of the wounded President was intractable pain in his legs and feet. This symptom failed to alert the doctors to the possibility of vertebral and spinal cord injury. Garfield died with sepsis after 80 days of intense national concern, and for the patient there was psychological, physical, and nutritional deprivation. His autopsy revealed the bullet was not in the pelvis as his doctors had expected, but adjacent to the first lumbar vertebra it had shattered. The trial and execution of Guiteau split the medical community into those that considered him insane and those who felt execution was justified. Guiteau was delusional and his brain revealed chronic inflammation and histological features suggestive of syphilis. At the time, and since, the propriety of the execution has been questioned.

Download full-text PDF

Source
http://dx.doi.org/10.1080/096470490953455DOI Listing

Publication Analysis

Top Keywords

death president
4
president assassin--errors
4
assassin--errors diagnosis
4
diagnosis autopsies
4
autopsies july
4
july 1881
4
1881 charles
4
charles julius
4
julius guiteau
4
guiteau shot
4

Similar Publications

Background: COVID-19 is a transmissible and infectious disease with symptoms similar to pneumonia, ranging from moderate to severe. This study investigated the psychological experiences of patients both during their illness and after their recovery.

Methods: The study employed purposive sampling and semi-structured interviews to gather insights from 13 COVID-19 survivors (7 women and 6 men).

View Article and Find Full Text PDF

Background: CheckMate 8HW prespecified dual primary endpoints, assessed in patients with centrally confirmed microsatellite instability-high or mismatch repair-deficient status: progression-free survival with nivolumab plus ipilimumab compared with chemotherapy as first-line therapy and progression-free survival with nivolumab plus ipilimumab compared with nivolumab alone, regardless of previous systemic treatment for metastatic disease. In our previous report, nivolumab plus ipilimumab showed superior progression-free survival versus chemotherapy in first-line microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer in the CheckMate 8HW trial. Here, we report results from the prespecified interim analysis for the other primary endpoint of progression-free survival for nivolumab plus ipilimumab versus nivolumab across all treatment lines.

View Article and Find Full Text PDF

Breast cancer is a multifaceted and prevalent malignancy, impacting a considerable proportion of women globally. Numerous signaling pathways intricately regulate cellular functions such as growth, proliferation, and survival. Among the various regulators, lncRNAs have emerged as significant players despite their inability to encode proteins.

View Article and Find Full Text PDF

Bridging translational gaps in Mexico's new science era.

Trends Mol Med

January 2025

Centro Interdisciplinario de Investigaciones Biológicas y Humanas (CIINBIOH), Universidad Autónoma Benito Juárez de Oaxaca (UABJO), Oaxaca, Mexico; R&D Group, Vice Presidency for Scientific Research and Innovation Imam Abdulrahman Bin Faisal University Dammam, Dammam, Saudi Arabia. Electronic address:

View Article and Find Full Text PDF

Background: Stroke is a significant cerebrovascular disease and remains one of the leading causes of death and disability worldwide. Insulin resistance has been strongly linked to the incidence of stroke. Employing characteristics of metabolic syndrome, the Metabolic Score for Insulin Resistance (METS-IR) accurately measures insulin resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!